SWX/ABT (SWX/ABT)

SIX Swiss Exchange: SWX/ABT · CHF

CHF 88.5

+1.00 (+1.1%)· Recorded snapshot

Market cap	156.2B
Revenue (ttm)	40.2B
Net income (ttm)	3.9B
EPS (ttm)	CHF 2.20
P/E (trailing)	40.2x
P/E (forward)	18.7x
Dividend	CHF 1.98 (2.24%)
Beta	0.68

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 40.2B
Net income (ttm): 3.9B
EPS (ttm): CHF 2.20
P/E (trailing): 40.2x
P/E (forward): 18.7x
Market cap: 156.2B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-11-03 14:30 UTC

Forward P/E18.7

P25 n/aP50 n/aP75 n/a

Trailing P/E40.2

P25 n/aP50 n/aP75 n/a

ROE10.6

P25 n/aP50 n/aP75 n/a

ROIC7.2

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All SWX/ABT indicators

Market & fundamental data

Available fields

236

Groups with data

Currency

USD

Showing 236 of 236 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	CHF
Country	United States
Country code	CH
Earnings date	2026-10-21
Employees	115,000
Employees change	7,000
Employees growth	6.09%
Enterprise value	CHF 178.9B
Exchange	SIX Swiss Exchange
Financial currency	USD
Financial report date	2026-09-30
First seen	2026-05-10
Fiscal year end	December
Founded	1888
Industry	Medical Devices
Is primary listing	No
ISIN number	US0028241000
Last earnings date	2026-10-21
Last refreshed	2026-11-03
Market cap	CHF 156.2B
Price	CHF 88.50
Price currency	CHF
Sector	Healthcare
SIC code	3845
Stock price date	2026-11-02
Symbol	swx/ABT
Website	https://www.abbott.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	50.21x
Average P/E ratio (3Y)	27.41x
Average P/E ratio (5Y)	28.1x
Earnings yield	2.49%
EV/Earnings	45.85x
EV/EBIT	27.36x
EV/EBITDA	17.69x
EV/FCF	27.96x
EV/Sales	4.53x
FCF / EV yield	3.58%
FCF yield	4.1%
Forward P/E	18.75x
Graham number	34.89562
Graham upside	-60.57%
Industry P/E	42.37x
Lynch fair value	CHF 11.06
Lynch upside	-87.51%
P/(FCF - SBC) ratio	26.87x
P/(OCF - SBC) ratio	20.78x
P/B ratio	3.62x
P/E ratio	40.21x
P/FCF ratio	24.4x
P/OCF ratio	19.28x
P/S ratio	3.88x
Price/EBITDA ratio	15.66x
Sector forward P/E	19.76x
Sector P/E	34.12x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	16.55%
EBITDA margin	24.79%
Effective tax rate	28.36%
FCF margin	16.8%
Gross margin	57.08%
Operating margin	16.55%
Pretax margin	13.61%
Profit margin	9.75%
Profit per employee	CHF 33,932
Profitable quarters	35
Profitable years	41
Revenue per employee	CHF 349,908
ROA	5.33%
ROA (5Y)	6.84%
ROCE	9.01%
ROE	10.58%
ROE (5Y)	19.7%
ROIC	7.25%
ROIC (5Y)	14.92%
SBC / revenue	1.54%
Tax / revenue	3.86%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	-66.24%
EPS growth (Q)	-43.69%
EPS growth (QoQ)	-0.12%
EPS growth 10Y	11.38%
EPS growth 3Y	-2.87%
EPS growth 5Y	-7.76%
EPS growth years	0
FCF growth	15.48%
FCF growth 3Y	12.55%
FCF growth 5Y	-1.97%
Gross profit growth	12.07%
Gross profit growth (Q)	17.95%
Gross profit growth 3Y	7.75%
Gross profit growth 5Y	2.62%
Net income growth	-66.37%
Net income growth (Q)	-44.04%
Net income growth (QoQ)	-0.86%
Net income growth 3Y	-3.11%
Net income growth 5Y	-8.3%
Net income growth years	0
OCF growth	9.61%
OCF growth 10Y	13.31%
OCF growth 3Y	9.95%
OCF growth 5Y	-1.4%
Operating income growth	-5.19%
Operating income growth (Q)	-33.06%
Operating income growth 3Y	5.37%
Operating income growth 5Y	-2.23%
Revenue growth	10%
Revenue growth (Q)	14.46%
Revenue growth (QoQ)	3.34%
Revenue growth 10Y	8.82%
Revenue growth 3Y	6.47%
Revenue growth 5Y	2.65%
Revenue growth quarters	12
Revenue growth years	2

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	CHF -1.7B
Depreciation and amortization	CHF 3.2B
EBIT	CHF 6.7B
EBITDA	CHF 10B
EPS	CHF 2.20
Financing cash flow	CHF 8.7B
Free cash flow	CHF 6.4B
Free cash flow minus SBC	CHF 5.8B
Gross profit	CHF 23B
Income taxes	CHF 1.6B
Investing cash flow	CHF -18.3B
Net borrowing	CHF 13.5B
Net cash flow	CHF -1.5B
Net income	CHF 3.9B
Operating cash flow minus SBC	CHF 7.5B
Operating income	CHF 6.7B
Revenue	CHF 40.2B
Stock-based compensation	CHF 587.3M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Book value per share	CHF 24.64
Debt / EBITDA	2.65
Debt / equity	0.63
Debt / FCF	4.27
Interest coverage	7.87
Net cash (debt)	CHF -22.6B
Net cash / market cap	-14.49%
Net debt / EBITDA	2.27
Net debt / equity	0.52
Net debt / FCF	3.54
Piotroski F-Score	5
Shareholders' equity	CHF 43.2B
Tangible book value	CHF -1.1B
Tangible book value per share	CHF -0.65
Total cash	CHF 4.7B
Total debt	CHF 27.3B
WACC	7.12%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.48
Current ratio	1.38
Inventory turnover	2.82
Quick ratio	0.8
Working capital	CHF 5.5B

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	0.25%
Dividend growth	7.29%
Dividend growth (10Y)	9.32%
Dividend growth (3Y)	7.26%
Dividend growth (5Y)	6.98%
Dividend growth years	12
Dividend payment date	2026-11-16
Dividend payment years	35
Dividend payout frequency	Quarterly
Dividend per share	CHF 1.98
Dividend yield	2.24%
Ex-dividend date	2026-10-15
Last dividend	CHF 0.64
Payout ratio	89.91%
Shareholder yield	2.49%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	121.25%
10Y return CAGR	10.35%
10Y total return	167.65%
150-day SMA	CHF 79.89
15Y price change	89.1%
15Y return CAGR	6.49%
15Y total return	156.9%
1D price change	1.14%
1M price change	9.26%
1M total return	9.97%
1W price change	2.91%
1W total return	2.91%
1Y price change	-12.38%
1Y return CAGR	-10.25%
1Y total return	-10.24%
20-day SMA	CHF 84.45
200-day SMA	CHF 82.01
20Y price change	50.38%
20Y return CAGR	4.42%
20Y total return	137.41%
3M price change	4.12%
3M total return	4.79%
3Y price change	-2.75%
3Y return CAGR	1.22%
3Y total return	3.71%
50-day SMA	CHF 85.43
50-day SMA vs 200-day SMA	50over200
52-week high	CHF 100.00
52-week high date	2026-01-28
52-week low	CHF 65.00
52-week low date	2026-05-13
5Y price change	-18.06%
5Y return CAGR	-1.95%
5Y total return	-9.39%
6M price change	23.78%
6M total return	25.4%
All-time high	CHF 128.00
All-time high date	2021-12-16
All-time low	CHF 16.63
All-time low date	1992-10-05
Average true range (ATR)	CHF 0.92
Average volume	0
Beta (5Y)	0.68
Change from 52-week high	-11.5%
Change from 52-week low	36.15%
Change from all-time high	-30.86%
Change from all-time low	432.33%
Monthly RSI	48.46
Previous close	CHF 87.50
Price vs 150-day SMA	10.78%
Price vs 20-day SMA	4.8%
Price vs 200-day SMA	7.91%
Price vs 50-day SMA	3.59%
Relative volume	5
RSI	64.44
Sharpe ratio	-0.47
Sharpe ratio (3Y)	-0.08
Sharpe ratio (5Y)	-0.27
Sortino ratio	-0.41
Sortino ratio (3Y)	0.23
Sortino ratio (5Y)	-0.05
Weekly RSI	56.62
YTD price change	-10.61%
YTD total return	-8.43%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	1.7B
Shares change (QoQ)	-0.29%
Shares change (YoY)	-0.25%
Shares held by insiders	0.48%
Shares held by institutions	80.98%
Short ratio	2 days

Deeper analysis on SWX/ABT

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this SWX/ABT report

Is a complete SWX/ABT research report available?

No complete published report is available for swx/ABT (SWX/ABT) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

SWX/ABT (SWX/ABT)

Price

Financial snapshot

Fair-value bridge

Latest news · SWX/ABT

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All SWX/ABT indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on SWX/ABT

Frequently asked questions